Litcius/Paper detail

Using Machine Learning to Predict the Future Development of Disease

Lanxin Miao, Xuezhou Guo, Hasan Abbas, Khalid Qaraqe, Qammer H. Abbasi

20202020 International Conference on UK-China Emerging Technologies (UCET)27 citationsDOIOpen Access PDF

Abstract

The objective of this research is to develop a longterm risk model for the development of cardiovascular disease (CVD) because of type-2 diabetes (T2D). We use the support vector machine (SVM) and the K-nearest neighbours algorithms on the dataset collected from a longitudinal study called Framingham Heart Study, to develop the prediction models. The dataset was first balanced by the Synthetic Minority Oversampling Technique algorithm. The SVM algorithm was then used to train the model, and after tuning the parameters and training for 1000 times, the average accuracy to correctly predict the prevalence of CVD due to T2D came out as 96.5% and the average recall rate was 89.8%. Similarly, we also applied the KNN algorithm to train the dataset, and the recall rate even reaches 92.9%. The advantages of our model are: 1) it can predict with high accuracy both the risk of development of T2D and CVD simultaneously; 2) it can be used without the expensive and tedious oral glucose tolerance test. The model yielded high-performance results after training on the Framingham Heart Study dataset.

Topics & Concepts

Support vector machineComputer scienceRandom forestArtificial intelligenceMachine learningFramingham Risk ScoreRecall rateOversamplingFramingham Heart StudyDiseaseMedicineInternal medicineBandwidth (computing)Computer networkArtificial Intelligence in HealthcareMachine Learning in HealthcareMachine Learning and Data Classification
Using Machine Learning to Predict the Future Development of Disease | Litcius